Amarin Corp Plc (AMRN)

[Number sleven]

Monk, I posted this because the similarities between the launch of the first statin and Vascepa. Including a pair of doctors making fictional side effect claims. (Sound familiar) Doctors are not prone to rapid changes. The markets need to reach a tipping point. This process starts with clinical research MD 's. Then it trickles down to the specialist. Eventually it works it's way down to the general practitioner. This process requires time. Statin medications didn't have an explosive start. Neither have we. In the absence of other options, this is just a matter of time.
Sleven,